{"version":"1.0","provider_name":"LDL-C Target \u05de\u05d7\u05e9\u05d1\u05d5\u05df","provider_url":"https:\/\/tools.e-med.co.il\/repatha","author_name":"\u05de\u05e2\u05e8\u05db\u05ea \u05d4\u05d0\u05d9\u05d2\u05d5\u05d3","author_url":"https:\/\/tools.e-med.co.il\/repatha\/author\/-12\/","title":"Cardiovascular Risk Assessment and Management - LDL-C Target \u05de\u05d7\u05e9\u05d1\u05d5\u05df","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"84F9vLOA9D\"><a href=\"https:\/\/tools.e-med.co.il\/repatha\/cardiovascular-risk-assessment-and-management\/\">Cardiovascular Risk Assessment and Management<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/tools.e-med.co.il\/repatha\/cardiovascular-risk-assessment-and-management\/embed\/#?secret=84F9vLOA9D\" width=\"600\" height=\"338\" title=\"&#8220;Cardiovascular Risk Assessment and Management&#8221; &#8212; LDL-C Target \u05de\u05d7\u05e9\u05d1\u05d5\u05df\" data-secret=\"84F9vLOA9D\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/tools.e-med.co.il\/repatha\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"The Israeli Society for Research, Prevention and Treatment of Atherosclerosis is happy to give Israeli and Worldwide healthcare providers a convenient app for cardiovascular risk assessment and management. The app is based on the European Systemic Coronary Risk Estimation (SCORE) and the 2014 update of the Israeli Guidelines for the Treatment of Hyperlipidemia. The SCORE [&hellip;]"}